Mezagitamab (Anti-CD38)

Mezagitamab (Anti-CD38) is a human, non-agonistic immunoglobulin G1 (IgG1) monoclonal antibody directed against the cell surface glycoprotein ADP-ribosyl cyclase 1 (CD38) with potential immunomodulating and antineoplastic activities. MW : 144.44 KD.

• Supplier: Selleck Chemicals
• Product #: A2819
• Sku #: A2819-1mg